Acute Pancreatitis: Acute pancreatitis, which includes fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has long been noticed in sufferers handled with GLP-one receptor agonists, which include semaglutide. Acute pancreatitis was observed in sufferers handled with Wegovy® in scientific trials. Wegovy® is contraindicated in sufferers with a private or household record https://anniev246rtu1.webdesign96.com/profile